BridgeBio Pharma Inc

BridgeBio Pharma Inc

BBIO

Market Cap$6.5B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BridgeBio Pharma IncBridgeBio Pharma Inc-9.7-41%--
$72.00

Target Price by Analysts

87.8% upsideBridgeBio Pharma Target Price DetailsTarget Price
$-9.00

Current Fair Value

123.5% downside

Overvalued by 123.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$6.50 Billion
Enterprise Value$5.98 Billion
Dividend Yield$0 (0%)
Earnings per Share$-2.88
Beta1.15
Outstanding Shares190,145,253

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-9.75
PEG-2.6
Price to Sales-
Price to Book Ratio-4.26
Enterprise Value to Revenue46.97
Enterprise Value to EBIT-8.87
Enterprise Value to Net Income-9
Total Debt to Enterprise0
Debt to Equity-0.01

Revenue Sources

No data

Insider Trades

ESG Score

No data

About BridgeBio Pharma Inc

CEO: Neil Kumar